NIVOLUMAB

97932 reported adverse events

Drug classes: Programmed Death Receptor-1 Blocking Antibody [EPC]

These side effects are most commonly reported by patients taking NIVOLUMAB:

# Side effect Count
0 DEATH 12098
1 MALIGNANT NEOPLASM PROGRESSION 9963
2 OFF LABEL USE 6485
3 DIARRHOEA 5336
4 FATIGUE 4264
5 PYREXIA 3792
6 INTENTIONAL PRODUCT USE ISSUE 3329
7 NAUSEA 3233
8 RASH 3143
9 DECREASED APPETITE 2949
See all common reactions for NIVOLUMAB

NIVOLUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED UVEITIS 128 0.6995
1 FULMINANT TYPE 1 DIABETES MELLITUS 605 0.5868
2 LEUKODERMA 104 0.5226
3 IMMUNE-MEDIATED HYPOPHYSITIS 224 0.4967
4 IMMUNE-MEDIATED ENCEPHALOPATHY 43 0.4831
5 LYMPHOCYTIC HYPOPHYSITIS 131 0.4746
6 ENDOCRINE TOXICITY 47 0.4608
7 IMMUNE-MEDIATED CYSTITIS 51 0.4435
8 IMMUNE-MEDIATED CHOLANGITIS 158 0.4401
9 IMMUNE-MEDIATED ENDOCRINOPATHY 66 0.4400
See all enriched reactions for NIVOLUMAB